Addex Therapeutics Ltd Share Price
Stocks
ADXN
CH0029850754
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Swiss Exchange
10:00:01 02/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.0226 CHF | 0.00% |
|
0.00% | -59.21% |
| 08/10 | Swiss Market Index Retreats; Novartis Shares Decline | MT |
| 08/10 | Addex Therapeutics' Neurosterix to Advance Schizophrenia Drug to Phase 2 Trials | MT |
| Market Cap | 49.81L 60.81L 54.36L 45.35L 85.04L 58Cr 86.92L 5.95Cr 2.4Cr 30Cr 2.28Cr 2.23Cr 96Cr | P/E 2024 |
0.8x | P/E 2025 | -0.88x |
|---|---|---|---|---|---|
| Enterprise Value | 33.77L 41.23L 36.85L 30.75L 57.66L 39Cr 58.93L 4.03Cr 1.63Cr 21Cr 1.55Cr 1.52Cr 65Cr | EV / Sales 2024 |
5.67x | EV / Sales 2025 | 28.1x |
| Free-Float |
60.59% | Yield 2024 * |
-
| Yield 2025 | - |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| ADXN | Delayed | |
CBOE
| 0QNV | Real-time | |
|
Boerse Muenchen
| APE | Real-time | |
|
Deutsche Boerse AG
| APE | Delayed | |
|
Börse Stuttgart
| APE | Delayed |
Last Transcript: Addex Therapeutics Ltd
| 1 month | +3.67% | ||
| 3 months | -46.19% | ||
| 6 months | -54.44% | ||
| Current year | -59.21% |
| 1 week | 0.02 |  | 0.02 |
| 1 month | 0.02 | | 0.02 |
| Current year | 0.02 | | 0.07 |
| 1 year | 0.02 | | 0.07 |
| 3 years | 0.02 | | 0.26 |
| 5 years | 0.02 | | 1.38 |
| 10 years | 0.02 | | 4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tim Dyer
CEO | Chief Executive Officer | 58 | 01/06/2013 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 40 | 01/06/2017 |
Roger Mills
CTO | Chief Tech/Sci/R&D Officer | 69 | 28/11/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Vincent Lawton
CHM | Chairman | 77 | - |
Tim Dyer
BRD | Director/Board Member | 58 | 01/01/2015 |
Ray Hill
BRD | Director/Board Member | 81 | 12/05/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/09/26 | Issuer sale | Chief Technology Officer | -8,85,674 | 0.4051% | ||
| 02/09/26 | Issuer sale | Director | -5,39,122 | 0.2466% | ||
| 02/09/26 | Issuer sale | Chief Financial Officer | -12,05,816 | 0.5515% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -65.02% | -56.54% | 60.47L | |
| -2.37% | -4.19% | +39.49% | +63.21% | 6.38TCr | |
| -2.87% | +0.23% | +11.11% | +68.89% | 5.64TCr | |
| +0.62% | +2.60% | +16.96% | +103.45% | 5.46TCr | |
| -3.33% | -7.49% | +19.39% | +43.57% | 4.41TCr | |
| -2.45% | -4.33% | +16.36% | +99.27% | 4.21TCr | |
| -1.64% | +0.63% | +219.80% | +824.67% | 4.1TCr | |
| -5.47% | +39.86% | +101.20% | +80.57% | 3.49TCr | |
| +0.21% | -1.23% | +14.81% | +47.35% | 3.28TCr | |
| -2.90% | +17.05% | -42.35% | +337.41% | 2.47TCr | |
| Average | -2.02% | +6.95% | +33.18% | +161.19% | 3.94TCr | |
| Weighted average by Cap. | -2.16% | +5.64% | +44.63% | +167.82% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4L 5L 4L 4L 7L 4.75Cr 7L 48.99L 19.76L 2.5Cr 18.79L 18.4L 7.91Cr | 2L 2L 2L 2L 3L 2Cr 3L 20.65L 8L 1.06Cr 8L 8L 3.33Cr |
| Net income | 70.56L 86.14L 76.99L 64.24L 1.2Cr 82Cr 1.23Cr 8.43Cr 3.4Cr 43Cr 3.23Cr 3.17Cr 136.04Cr | -67.28L -82.14L -73.42L -61.26L -1.15Cr -78Cr -1.17Cr -8.04Cr -3.24Cr -41Cr -3.08Cr -3.02Cr -129.73Cr |
| Net Debt | -33L -40.28L -36.01L -30.04L -56.33L -38Cr -57.58L -3.94Cr -1.59Cr -20Cr -1.51Cr -1.48Cr -64Cr | -16.04L -19.58L -17.5L -14.6L -27.38L -19Cr -27.99L -1.92Cr -77.29L -9.79Cr -73.51L -71.96L -31Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | CHF 0.0226 | 0.00% | 58,222 |
| 30/26/30 | CHF 0.0226 | +9.71% | 4,79,014 |
| 29/26/29 | CHF 0.0206 | -0.96% | 1,66,657 |
| 28/26/28 | CHF 0.0208 | 0.00% | 2,97,775 |
| 27/26/27 | CHF 0.0208 | -5.45% | 99,101 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ADXN Stock
Select your edition
All financial news and data tailored to specific country editions
